Monday: First Investment by the Former CEO of Sanofi? Just a €560M Virtual Biotech… #Easy
Tuesday: 2015 Review: What Exciting Developments Have Been Made in Neurodegenerative Disease?
Wednesday: Novartis Attacks Amgen. Amgen wants to Ruin Roche – The New Biosimilar War!
Thursday: A €1.3M Start-Up is Engineering Baker’s Yeast to Make Green House Gases Useful
Friday: Could this new TCR Lung Cancer Trial Save Adaptimmune from a Volatile Stock Situation?
Explore other topics: